Perceptic, a startup founded by former Palantir executives, has emerged from stealth with $12 million in seed funding to automate the entire drug discovery process. The company's AI platform aims to integrate disparate AI tools and data for pharmaceutical companies, covering areas from asset scouting to clinical trial design. Perceptic's software is already in use by major pharmaceutical clients, including CSL, and is designed to be model-agnostic, allowing integration with existing customer infrastructure. AI
IMPACT Accelerates AI adoption in pharmaceutical R&D, potentially speeding up drug development timelines.
RANK_REASON Startup emerges from stealth with significant seed funding and notable backers. [lever_c_demoted from significant: ic=1 ai=0.7]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
